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Novel Characterization of MHC Class II–Negative
Population of Resident Corneal Langerhans
Cell–Type Dendritic Cells
Pedram Hamrah, Qiang Zhang, Ying Liu, and M. Reza Dana
PURPOSE. The presence of antigen-presenting cells (APCs) such
as Langerhans cells (LCs), an epithelial form of dendritic cells
(DCs), in corneal tissue is critical for generation of immune
responses, including graft rejection and herpetic keratitis. The
purpose of this study was to characterize the distribution and
major histocompatibility complex (MHC) antigen expression
of corneal LCs.
METHODS. Normal and inflamed corneas were excised from
BALB/c mice, and immunofluorescence staining for CD11c,
CD11b, CD45, CD80 (B7.1), CD86 (B7.2), CD3, and MHC class
II (Ia) was performed by confocal microscopy on wholemount
corneal epithelium.
RESULTS. CD11c MHC class II–positive LCs were found in the
limbus and corneal periphery, but not in the center of the
normal cornea. These cells were CD45 positive, exhibiting
bone marrow derivation, and CD3 and CD11b negative, con-
firming a DC lineage. Additionally, these cells were CD80 and
CD86 negative, reflecting an immature phenotype. In the cen-
tral and paracentral areas, however, significant numbers of
CD11c LCs were detected that expressed no MHC class II. It
is important to note that although the density of the LCs
declined from the limbus toward the center of the cornea, they
were always present. In the inflamed cornea, the expression of
MHC class II and costimulatory molecules CD80 and CD86 was
significantly enhanced, and present in all parts of the cornea, in
contrast to the normal cornea.
CONCLUSIONS. The present study demonstrates for the first time
the phenotype and distribution of MHC class II–negative LCs in
the murine corneal epithelium. In the inflamed cornea, the LCs
become activated as reflected by expression of B7 costimula-
tory markers. These changes in activation markers may provide
additional information for devising novel immunomodulatory
strategies. (Invest Ophthalmol Vis Sci. 2002;43:639–646)
L angerhans cells (LCs) were originally described by PaulLangerhans in 1868 in the skin epidermis,1 but their func-
tion and origin remained obscure for more than a century. It
has now been established that LCs are a population of dendritic
cells (DCs) that mediate antigen presentation.2 The current
dogma holds that these cells represent a discrete leukocyte
population of specialized or “professional” antigen-presenting
cells (APCs) with an extraordinary capacity for initiating T-
lymphocyte responses.2 The cardinal properties of APCs in-
clude their ability to take up, process, and present antigen;
migrate selectively through tissues; and stimulate and direct
T-lymphocyte–dependent responses. As such, LCs are the crit-
ical sentinel cells of the immune system in epithelial tissues
that perform immune surveillance.
In the cornea, the presence of histologically similar atypical
“onkeratinocytes” was noted in 1867.3 Corneal LCs, similar to
skin LCs, are bone marrow–derived cells4–7 that represent the
professional APCs of the ocular surface.8,9 Constitutive expres-
sion of major histocompatibility complex (MHC) class II anti-
gens is thought to be a characteristic feature of DCs (including
LCs) in the corneal epithelium.9–15 Under nonpathologic cir-
cumstances, LCs are the only cells that constitutively express
MHC class II (Ia) molecules in the corneal epithelium10 and in
the epidermis of the skin.16,17 MHC antigens have been impli-
cated as important components in both the generation and
expression of the immune response.18 Over the past several
decades, the search for corneal APCs, largely reliant on their
MHC class II expression, has led to the opinion that the normal
central cornea is essentially devoid of APCs, regardless of
species or strain,9,12,19–29 although rare MHC class II–positive
cells have been described occasionally.11,14,24,30–32 Despite
the purported absence of these cells in the normal cornea, it is
generally acknowledged that a number of corneal stimuli (e.g.,
infection, trauma) can induce LC migration into the cornea
from the limbus.33–39
There are important biological implications for the conten-
tion that the normal cornea is devoid of a DC population. For
example, the putative absence of a normal endowment of LCs
in the central cornea has led many investigators to propose that
the priming of recipient T cells in corneal transplantation relies
practically exclusively on migration of host APCs into the
cornea, where they can process antigens and then present
processed peptides to naive T cells in lymphoid organs through
the indirect pathway of sensitization.8,37 This is in contrast to
other forms of solid organ transplantation, such as heart or
kidney, where the donor tissue contains significant numbers of
APC passenger leukocytes that can directly sensitize host T
cells by the concomitant expression of donor MHC and pro-
cured antigens.40 In addition to their role in transplantation,
the number of class II–positive LCs present in the central areas
of the cornea also correlates with the promotion of inflamma-
tory responses in herpes simplex keratitis and the resultant
degree of damage to the cornea.34,41–45
In the present study we show, using highly sensitive con-
focal microscopy techniques, that the normal uninflamed cor-
nea is in fact endowed with a significant number of MHC class
II–negative LC-type DCs that are in an immature state. In
contrast, the inflamed cornea is characterized by activated LCs,
reflected by the upregulated expression of class II MHC and
costimulatory molecules, including CD80 (B7.1) and CD86
(B7.2).
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METHODS
Experimental Animals
Seven to 14-week-old male BALB/c and C57BL/6 mice (Taconic Farms,
Germantown, NY) were used in these experiments. For the transplan-
tation experiments BALB/c (H-2d) mice were used as recipients and
C57BL/6 (H-2b) mice were used as donors. All animals were treated
according to the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research.
Cauterization of Corneal Surface
Two weeks before tissue procurement, animals were deeply anesthe-
tized with an intraperitoneal injection of 3 to 4 mg ketamine and 0.1
mg xylazine and were placed under the operating microscope. Using
the tip of a hand-held thermal cautery (Aaron Medical Industries Inc.,
St. Petersburg, FL), five light burns were applied to the central 50% of
the cornea, as previously described.35 Immediately after surgery, eryth-
romycin ophthalmic ointment was applied. Corneas were excised 1, 3,
7, and 14 days after cautery application and assessed in immunohisto-
chemical studies as described in later sections.
Transplantation
Orthotopic penetrating keratoplasty was performed as described pre-
viously.46 Briefly, the recipient cornea was marked with a trephine and
excised with microscissors to a size of 1.5 mm. The donor cornea was
excised with a 2.0-mm trephine (Storz Instrument Co., St. Louis, MO)
and transplanted into the host corneal bed with eight interrupted 11-0
nylon sutures (Sharpoint, Vanguard, TX). Nongrafted donor buttons
and transplanted corneas were excised at 2, 6, 16, and 24 hours after
surgery and used in immunohistochemical studies.
Transmission Electron Microscopy
Freshly excised healthy BALB/c corneas were fixed in Karnovsky so-
lution. After three washes in cacodylate buffer, corneas were postfixed
for 1.5 hours in 1% osmium tetroxide in the same buffer. Corneas were
washed with H2O, stained in aqueous 2% uranyl acetate, dehydrated,
and embedded in Epon. Corneal sections were cut at 60 Å and viewed
under a transmission electron microscope (model 410; Philips, Eind-
hoven, The Netherlands).
Antibodies
The primary antibodies (all from PharMingen, San Diego, CA), their
specificity, and their respective control antibodies (all from Phar-
Mingen), are summarized in Table 1. Secondary antibodies were Cy5-
conjugated goat anti-hamster IgG (PharMingen), rhodamine-conjugated
goat anti-rat IgG, and FITC-conjugated goat anti-rat IgG (Santa Cruz
Biotechnology, Santa Cruz, CA).
Immunohistochemical Studies
Normal, inflamed (cauterized), and transplanted corneas were excised
from BALB/c mice. Corneal-conjunctival epithelium was obtained in
whole sheets by a modification of a technique previously described.47
Briefly, freshly excised corneas were immersed in phosphate-buffered
saline (PBS), containing 20 mM EDTA (Sigma Chemical Co., St. Louis,
MO) at 37°C for 1 hour. The epithelium was separated from the
underlying stroma with forceps and washed in PBS.
Epithelial sheets were fixed in acetone for 15 minutes at room
temperature (RT). To block nonspecific staining, epithelial sheets were
incubated in 2% bovine serum albumin (BSA) diluted in PBS (PBS-BSA)
for 15 minutes before addition of primary and secondary antibodies.
Purified primary antibodies or isotype-matched control antibodies
were applied to the samples for 2 hours, followed by a 60-minute
incubation of a second FITC- or phycoerythrin (PE)-conjugated primary
antibody or by incubation of the secondary antibodies for 60 minutes
(all diluted for optimal concentrations in PBS-BSA). Epithelial sheets
were further stained with secondary antibodies only, as additional
controls. All staining procedures were performed at RT, and each step
was followed by three thorough washings in PBS for 5 minutes each.
Finally, epithelial sheets were covered with mounting medium (Vec-
tor, Burlingame, CA) and examined with a confocal microscope (Leica,
Heidelberg, Germany). Epithelial sheets were examined at 160-fold and
400-fold magnifications using a 10 eyepiece and 16 or 40 objec-
tive lens. Central, paracentral, and peripheral areas for each cornea
were assessed separately. At least three different corneas were exam-
ined per each double-staining experiment. Five to eight different fields
were analyzed for each specimen using a grid and the numbers aver-
aged. For analytical purposes, the cornea was divided in three different
areas. The central area was defined as the area within 0.5 mm of the
corneal center. The paracentral region was the area between 0.5 and
1.0 mm of the center. The periphery was defined as being within a 1.0-
to 1.5-mm radial distance from the center. The limbus was defined as
the intervening zone between the cornea and conjunctiva, slightly
more than 1.5 mm radially from the corneal center.
Student’s t-test was used to compare the number of cells with
specific surface markers in different portions of the cornea. P  0.05
was considered significant.
RESULTS
Phenotype, Distribution, and Density of LCs in
the Normal Cornea
To characterize the LCs of the corneal epithelium, epithelial
sheets were double stained with a combination of antibodies.
CD45 staining (the panleukocyte marker) showed large num-
bers of dendrite-shaped cells throughout the corneal epithe-
lium (Fig. 1A). The density of these cells decreased from the
limbus toward the center. Double staining with MHC class II
antibody showed expression of MHC class II only at the limbus
and periphery of the cornea, whereas the CD45 cells in the
paracentral and central areas were all negative for MHC class II
(Fig. 1B). Staining with isotype controls instead of primary
antibodies showed no labeling (Fig. 1C). All CD45-labeled cells,
both in the periphery and in the center of the cornea, had the
TABLE 1. Monoclonal Antibodies Used in Labeling
Primary Antibody
(Clone) Specificity Control Antibody
Iad-FITC (39-10-8) BALB/c mouse class II MHC antigen Mouse IgG 3-FITC
Iab-FITC (AF6-120.1) C57BL/6 mouse class II MHC antigen Mouse IgG 2a-FITC
CD11c (HL3) Integrin DC/LC marker Hamster IgG
CD11b-FITC (M1/70) MAC-1, integrin monocyte-macrophage marker Rat IgG 2b-FITC
CD45 (30-F11) Panleukocyte marker Rat IgG 2b
CD80-FITC (16-10A1) B7.1 costimulatory molecule Hamster IgG
CD86-PE (GL1) B7.2 costimulatory molecule Rat IgG 2a
CD3e-FITC (145-2C11) T-lymphocyte marker Hamster IgG
PE, phycoerythrin.
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classic dendritic cell morphology of LCs, as shown at higher
magnifications (Figs. 2A, 2B). The same cells, however, were
all MHC class II negative (Fig. 2C) in paracentral and central
areas of the cornea.
Double labeling of epithelial sheets with CD11c and B7
(CD80 or CD86) costimulatory molecules showed that all
CD11c cells in the normal uninflamed cornea were negative
for both CD80 (Fig. 3) and CD86 (results not shown). Further
analysis showed that all the dendritic-shaped cells were posi-
tive for CD11c, a marker for DCs, and negative for CD11b
(monocyte marker) and CD3 (T cell marker), confirming their
DC lineage.
The results on cell distribution and cell surface molecules in
the normal cornea are summarized in Figure 4: CD45–
CD11c LCs decreased in density from the periphery of the
cornea toward the center. Nearly one half of these cells were
MHC class II positive in the periphery, but there was no
expression of MHC class II in the central or paracentral areas.
Regardless of localization of MHC class II expression, all sam-
ples were negative for CD11b, CD3, CD80c, and CD86.
In addition to the immunohistochemical studies, transmis-
sion electron microscopy (TEM) was performed to confirm
presence of these bone marrow–derived cells in the cornea.
TEM demonstrated the presence of numerous dendritic cells
with long processes interdigitating among the corneal epithe-
lial cells (Fig. 5A). A subset of these cells contained multilami-
nated Birbeck granules (Fig. 5B), a specific marker for LCs,
suggesting that these cells represent an LC phenotype.
Distribution and Density of LCs
in the Inflamed Cornea
The cell surface phenotype of corneal LCs changed dramati-
cally in corneal inflammation. CD45 and CD11c double stain-
FIGURE 1. Corneal, unlike limbal,
CD45 cells were found to be MHC
class II negative. Confocal micro-
graphs of CD45 (red) and CD11c
(green) double-stained sections
show that all CD45 bone marrow–
derived cells were CD11c positive
(yellow) in the corneal periphery
(A). To evaluate MHC class II expres-
sion (Iad, green) by CD45 cells
(red) wholemounted corneal epithe-
lial sheets were double stained.
CD45 cells were present through-
out the cornea, with the density de-
creasing from the limbus (lower
right corner) toward the center of
the cornea (upper left corner) (B).
The same cells are MHC class II–posi-
tive in the limbus and periphery of
the cornea (yellow), but not in the
paracentral and central areas (B).
Staining with the CD45 isotype con-
trol (C) and CD11c isotype control
(D) showed no staining (C). Magnifi-
cation, 160.
FIGURE 2. Confocal micrographs show MHC class II–negative LCs in the center of the corneal epithelium.
Wholemounted corneal epithelial sheets were double stained with anti-CD45 and MHC class II or with
anti-CD11c and MHC class II. (A) Center of the cornea contained CD45 dendritic leukocytes. CD11c
expression of these cells in the center of the cornea provides evidence that they were of DC lineage (B)
and the higher magnification (C) shows typical dendritic morphology. The CD45–CD11c cells in the
center did not express MHC class II antigens, as reflected by absence of staining with anti-Ia. Magnification:
(A, C) 400; (B) 1000.
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ing with MHC class II showed that the density of central LCs
increased after cautery application. Furthermore, in BALB/c
corneas, a subset of LCs in the center and paracentral areas of
the cornea uniformly expressed MHC class II by day 3 after
cauterization (Figs. 6A, 6B). The number of MHC class II–
positive cells increased through 14 days after cautery. In addi-
tion, there was novel expression of CD80 and CD86 (B7 co-
stimulatory molecules) by CD11c cells throughout the
corneas, uniformly by day 3 and at later time points (Fig. 7).
The expression of MHC class II and B7 by epithelial DCs, was
first observed around the (central) cautery sites at day 3,
whereas the paracentral areas between the cautery sites and
the limbus remained MHC class II negative. By days 7 and 14
after cautery, these sites also contained class II– and B7-positive
cells.
The results on cell distribution and cell surface molecules in
inflamed corneas at day 14 after cautery are summarized in
Figure 8: The number of leukocytic (CD45) cells in the
peripheral, paracentral, and central areas of the cornea in-
creased by 100%, 43%, and 29%, respectively (P  0.005, P 
0.09, P  0.31, respectively) compared with the normal cor-
nea. This increase consisted largely of a DC population as
suggested by CD11c expression (Fig. 8). In addition to changes
in cell number, cells detected in the central and paracentral
areas also showed upregulated MHC class II expression in the
inflamed cornea. Enhanced expression of MHC class II was
particularly apparent in the paracentral and central areas of the
cornea. Put another way, although in the inflamed setting the
absolute number of MHC class II cells was still higher in the
periphery than in the center, the relative increase in class II
expression was more marked in the center of the cornea, in
that there was virtually no expression of class II by these cells
in the uninflamed setting. In addition, inflammation was also
associated with enhanced expression of the B7 costimulatory
markers, CD80 and CD86, indicating the relative maturation of
these cells and their greater potential capacity for sensitization.
Expression of MHC Class II by Donor Corneal
Cells in Transplantation
The presence (or absence) of donor MHC class II antigen in the
corneal graft has important implications for the mechanisms by
which graft-recipient hosts become sensitized to transplanted
antigens.8,37,40 To determine whether the enhanced detection
of MHC class II–positive cells in grafts is (solely) due to influx
of host leukocytes or also due to upregulated expression of
resident donor LCs (as described earlier), we performed dou-
ble staining against the DC marker CD11c and donor-type MHC
of C57BL/6 mice (Iab) at different time points after transplan-
tation into BALB/c (Iad) mice. Staining for donor-derived MHC
class II on nongrafted corneal buttons and at 2, 6, and 16 hours
after corneal transplantation showed no expression of donor
MHC class II; however, as early as 24 hours after corneal
transplantation, novel expression of donor class II was de-
tected (Fig. 9). These MHC class II–positive donor cells were
CD11c and CD45 positive. An interesting observation at the
early time points when no staining for donor MHC class II was
detected was a centrifugal migration of MHC class II–negative
CD45CD11c cells toward the graft–host border (Fig. 9,
arrows).
DISCUSSION
The present study indicates that resident MHC class II–negative
LCs are present in the epithelium of the normal murine cornea.
Previous studies in guinea pig, hamster, mouse, and human
have established that MHC class II–positive LCs are present in
the epithelium of the conjunctiva and peripheral cornea but
are essentially absent from the central cornea.9,12,19–29 The
FIGURE 4. Enumeration of multiple cell surface phenotypic markers,
based on location, in the uninflamed cornea. Corneas of BALB/c mice
were excised, epithelial sheets removed and LC densities in the pe-
riphery, paracentral, and central areas of the cornea assessed sepa-
rately with different markers. The data indicate the presence of large
numbers of MHC class II–negative LCs in the paracentral and central
regions of the cornea. The mean cells per square millimeter SD from
five to eight fields of at least three corneas per staining were compared.
FIGURE 3. LCs throughout the nor-
mal corneal epithelium were CD80
negative. Large numbers of CD11c
cells were present in the corneal pe-
riphery (A). However, these cells did
not express the B7 costimulatory
molecules in the uninflamed cornea
(B). Results were similar for CD86
(not shown). Magnification, 400.
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characteristic high expression of MHC class II by professional
APC (including DCs and LCs) populations, on the one hand,
coupled with the failure to routinely detect class II–positive
cells in the uninflamed cornea on the other, has led to the
conclusion that the cornea is devoid of resident APCs.9,12,19–29
Using an immunofluorescence double-staining technique
applied to confocal microscopy, we observed two phenotypi-
cally distinct populations of leukocytes throughout the corneal
epithelium: a MHC class II–positive population, located in the
periphery of the cornea and the limbus, and a MHC class
II–negative population, located in the central areas of the
normal cornea. TEM studies confirmed the presence of den-
dritic-shaped cells in the central corneal epithelium; moreover,
a subset of these cells contained Birbeck granules, identifying
them as having an LC lineage. Given that these cells collec-
tively exhibit dendritic morphology and, except for MHC class
II expression, have identical expression (or absence of expres-
sion) of cell surface markers (CD45, CD11b, CD11c,
CD3, CD80, CD86), we believe that they represent an
LC-type DC population.48 The absence of CD80 or CD86 ex-
pression by these cells regardless of their location is character-
istic of LCs in normal uninflamed tissues48,49 and defines these
cells as being in an immature or precursor stage. The negative
expression for CD3 and CD11b excludes the presence of
T-cells (including Thy-1 positive dendrite-shaped T-cells), and
monocytes-macrophages in this lineage.
The MHC class II–positive LCs in the periphery account for
slightly more than half of the total resident LCs (CD11c
CD45) in the cornea. The MHC class II–positive LC density of
100 cells/mm2 in the periphery correlates with results previ-
ously obtained by other groups.9,50 However, to our knowl-
FIGURE 5. Transmission electron micrograph of central corneal LCs.
(A) The center of normal uninflamed corneas contained numerous
dendritic cells (arrow) with long processes interdigitating between
epithelial cells (arrowheads) as seen by TEM. (B) Typical multilami-
nated Birbeck granules, a specific marker exhibited by some LCs can
be found on a subset of these cells (B). Magnification: (A) 7,500; (B)
52,500; (B, inset) 150,000.
FIGURE 6. Inflamed eyes contained MHC class II–positive LCs. Cor-
neas of BALB/c mice received cautery in the central 2 mm, and
wholemounted corneal epithelial sheets were assessed for expression
of MHC class II in the center of the cornea. Two representative
sections are shown (A, B). Double staining was performed for CD11c
(red) and MHC class II (green), demonstrating that unlike the absent
expression of MHC class II in the normal uninflamed cornea, some of
these LCs expressed MHC class II (yellow) (A, B). Magnification,400.
FIGURE 7. Corneal dendritic cells in inflamed corneas expressed co-
stimulatory molecules. Double staining of inflamed (cauterized) whole-
mounted corneal epithelial sheets with MHC class II (IAd; green) and
B7.2/CD86 (red) shows significant numbers of MHC class II–positive
cells in the paracentral region of the cornea. Many of these cells also
coexpressed costimulatory molecules (yellow). A representative micro-
graph is shown; similar results were obtained with B7.1/CD80. Mag-
nification, 400.
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edge, we are the first group to report the presence of MHC
class II–negative LCs in the cornea. In 1964, when LCs were
thought to be melanocytes, Segawa et al. described three
different populations of LCs in the human cornea.51 One of
these populations, the “nonpigmented dendritic cell” was
found in “all” parts of the cornea, including the center of the
epithelium. In retrospect, it is not clear whether Segawa et al.
were looking at the same cells as are described in this study. In
several studies, MHC class II–negative LCs have been described
in the skin.52–55 Because CD1a is a highly reliable indicator for
noncorneal LCs, those studies demonstrate that CD1a LCs
may be class II negative in the skin epidermis.
The comparison between CD1a and MHC class II antigen
expression, is not possible in the corneal epithelium, however,
because corneal LCs do not express the CD1a antigen, in
contrast to their counterparts in the skin.31,56,57 Therefore, it
may not be surprising that the novel MHC class II–negative LC
population described herein was not detected previously. In
addition, our studies are based on confocal microscopic eval-
uation of corneal epithelial sheets, which has the advantage of
examining multiple layers over a broad surface area. In our
experience, even with confocal microscopy, detection of LC
populations in the cornea is very difficult in cross-sectional
studies, because the transection of the LCs makes it difficult to
evaluate these cells’ morphology. This may explain why some
investigators have described occasional class II dendrite-like
cells11,14,24,30–32 in the cross-sectioned cornea, but were un-
able to make any firm conclusions regarding their identity.
We found that in inflammation, the expression of MHC class
II and B7 molecules (CD80 and CD86) is potently upregulated.
This upregulation was observed in cauterized corneas uni-
formly at day 3 after cauterization: first near the cautery sites
and later throughout the cornea. Although cells migrating into
the cornea from the limbus also contribute to the increased
density of MHC class II and B7 cells, our data suggest that
most of these cells, especially in the central and paracentral
areas, are resident LCs. There are several lines of evidence to
support this: First, although the total number of CD11c cells
increased from 80/mm2 in the normal cornea to 103/mm2 in
the inflamed cornea, the number of MHC class II cells in-
creased from 0/mm2 to 51/mm2, suggesting that recruitment of
cells into the corneal center was not entirely responsible for
changes in MHC class II expression. Second, at early time
points after cautery, MHC class II and B7 positive cells were
first present around cautery sites in the corneal center,
whereas the peripheral sites were still negative for these acti-
vation markers, suggesting that cells expressing these markers
were not simply being recruited from the periphery. Third, in
the transplantation experiments, we noted novel expression of
donor-derived MHC Ia antigens among the graft’s CD11c cells
24 hours after transplantation, similarly suggesting that recruit-
ment of cells from the (host) periphery could not entirely
explain the upregulation of MHCs in the graft.8,32,37 Moreover,
the negative expression of donor MHC antigens at early time
points after transplantation rules out contamination as a cause
of this expression. We also noted that the CD11c cells migrated
centrifugally toward the graft–host interface before class II
upregulation, suggesting that the environment at the graft–
host border plays a major role in the upregulation of class II in
these cells.
Candidate molecules that are known to upregulate expres-
sion of costimulatory and MHC class II molecules and induce
the maturation of DCs and LCs, include tumor necrosis factor
(NF)-, granulocyte-macrophage colony-stimulating factor
(GM-CSF), and interleukin (IL)-1.58–62 Previous studies by our
group using the IL-1 receptor antagonist (IL-1ra) to suppress
IL-1 function locally, showed that topical IL-1ra suppresses LC
activities and ultimately promotes ocular immune privilege and
corneal transplant survival.63,64 One way IL-1ra’s immune mod-
ulatory effect could be explained is its suppression of limbal
(host) APC recruitment into the graft, which would result in
decreased capacity for antigen processing. However, in view of
our current data, we speculate that one additional mechanism
by which anti-inflammatory agents may downmodulate corneal
immunity is by suppressing the maturation of resident APCs in
FIGURE 8. Enumeration of multiple cell surface phenotypic markers,
based on location, in the inflamed cornea. The data indicate that
CD45–CD11c cells migrated into the cornea. Moreover, a significant
number of cells upregulated expression of MHC class II and B7 co-
stimulatory molecules after induction of inflammation. Mean cells per
square millimeter SD from five to eight fields of at least three corneas
per staining are compared.
FIGURE 9. MHC class II–negative corneal button shows upregulated
donor-type MHC class II 24 hours after transplantation. Corneal trans-
plantation was performed using C57BL/6 (Iab) mice as donors and
BALB/c (Iad) mice as recipients. The central donor cornea, which was
devoid of MHC class II (Iab)–positive cells before transplantation,
exhibited donor-derived MHC class II–positive cells (arrows) as early
as 24 hours after transplantation. These cells were CD11c positive in
double-stained corneas. Magnification, 400.
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the cornea. This hypothesis is supported by previous data from
our laboratory in which we showed that intracorneal injection
of LCs can promote generation of immunity to intracameral
antigens, but that suppression of IL-1 activity (even in the
presence of high numbers of intracorneal LCs) abrogates the
capacity of LCs to promote immunity to ocular antigens.64
Hence, we propose that the absence (or generation) of immu-
nity to corneal antigens cannot be explained simply by the
numbers of APCs present in the cornea, but also must take into
account these cells’ maturation state.
The cells described herein fit the phenotypic characteristics
of progenitor or immature APCs. Progenitor and immature
APCs (including DCs and LCs) in general have negligible to
absent MHC class II and B7 costimulatory expression.65 Al-
though immature LCs are highly capable of antigen uptake and
processing, in contrast to mature LCs, they have a weak stim-
ulatory capacity for activating T cells, due to their failure to
provide naive T cells with requisite costimulatory signals.65
However, exposure of these cells to the proper (proinflamma-
tory) cytokine microenvironment promotes their maturation,
during which these cells lose their capacity to process antigens
and instead gain the capacity to stimulate T cells. Our data
suggest that the proinflammatory milieu induced by cauteriza-
tion or transplantation of the cornea is associated with matu-
ration of resident corneal LCs.
Little is known about the exact molecular mechanisms that
regulate LC maturation in the cornea on the one hand, or those
that retain large numbers of these LCs in an immature state on
the other. It is known that prostaglandin E2
66 and cytokines
such as TGF- and IL-1049, 67 have a profound capacity to
suppress the stimulatory role of LCs and to downregulate MHC
class II expression. Given that there is constitutive expression
of a variety of immunosuppressive factors in the eye (including
the cornea), it is attractive to propose that active suppression
of LC maturation, with associated absence of MHC class II and
costimulatory molecule expression, may in fact represent an
important facet of ocular immune privilege.
The presence of an MHC class II–negative subpopulation of
immature LCs in the cornea may have important implications
for a wide range of immunoinflammatory responses in the
anterior segment, including alloimmune, autoimmune, and in-
nate immune responses. Further studies are needed, to deter-
mine the molecular mechanisms that regulate the maturation
of these cells and their immunobiologic phenotype in stimu-
lating (or tolerizing) T cells generated in response to ocular
antigens.
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